Hua Medicine (HK:2552) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hua Medicine, a company incorporated in the Cayman Islands, has announced that effective July 19, 2024, their principal place of business in Hong Kong will move from its current location to the Hang Seng Wanchai Building. The notice was issued by the CEO, Dr. Li Chen, confirming the company’s continued presence in the region. Investors and clients should note the change in address for any direct inquiries or business relations.
For further insights into HK:2552 stock, check out TipRanks’ Stock Analysis page.